MARKET

GLYC

GLYC

GlycoMimetics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.060
+0.150
+3.84%
Opening 15:23 08/10 EDT
OPEN
3.910
PREV CLOSE
3.910
HIGH
4.070
LOW
3.860
VOLUME
254.54K
TURNOVER
--
52 WEEK HIGH
6.72
52 WEEK LOW
1.820
MARKET CAP
193.76M
P/E (TTM)
-3.5524
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GLYC stock price target is 9.25 with a high estimate of 15.00 and a low estimate of 4.000.

EPS

GLYC News

More
3 “Strong Buy” Healthcare Stocks Under $5 That Could See Outsized Gains
The stock market just keeps going up, up and away. COVID-19 continues to have a choke hold on the economy, yet stocks have pulled off an incredible recovery, with the S&P 500 up 50% since its March low point. But can the index keep the rally alive?Credit Suiss
TipRanks · 3d ago
GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha · 08/01 00:33
GlycoMimetics Inc (GLYC) Q2 2020 Earnings Call Transcript
Good morning, and thank you all for joining GlycoMimetics Corporate Update Conference Call. The webcast replay will also be available in the Investor Relations section of the Company's website for 30 days. Joining me on the call today from GlycoMimetics are
Motley Fool · 07/31 22:30
GlycoMimetics EPS beats by $0.06
Seeking Alpha · 07/31 12:29
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2020
GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the second quarter ended June 30, 2020, and highlighted recent company events. Cash and cash equivalents at June 30, 2020 were $149.8 million.
Business Wire · 07/31 12:00
GlycoMimetics to Report Second Quarter Financial Results on July 31, 2020
GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will host a conference call and webcast to report its second quarter financial results on Friday, July 31, 2020, at 8:30 a.m. ET.
Business Wire · 07/24 13:15
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GlycoMimetics, Inc. (the "Company") (NASDAQ:GLYC) today announced that the compensation committee of the Company’s Board of Directors approved the grant on July 6, 2020 of a non-qualified stock option award to purchase an aggregate of 12,200 shares of its comm
Business Wire · 07/10 13:00
Were Hedge Funds Right About Piling Into GlycoMimetics, Inc. (GLYC)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 06/30 22:30

Industry

Biotechnology & Medical Research
+0.21%
Pharmaceuticals & Medical Research
+0.14%

Hot Stocks

Symbol
Price
%Change

About GLYC

GlycoMimetics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of glycomimetic drugs. The Company operates through the identification and development of glycomimetic compounds segment. Its drug candidates include Uproleselan, GMI-1687, GMI-1359, Galectin Antagonists and Rivipansel. Uproleselan is a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia and a hematologic cancer. As a life-cycle extension to uproleselan, it has designed an antagonist of E-selectin, GMI-1687, that is suitable for subcutaneous administration. GMI-1359 is designed to inhibit both E-selectin and CXCR4. The Galectin-3 is a carbohydrate-binding protein. Rivipansel is a glycomimetic drug that acts as a pan-selectin antagonist that binds to all three members of the selectin family, E-, P- and L-selectin, for the treatment of vaso-occlusive crisis.
More

Webull offers kinds of GlycoMimetics Inc stock information, including NASDAQ:GLYC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLYC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GLYC stock methods without spending real money on the virtual paper trading platform.